DE69716434D1 - Verwendung von lysin zur behandlung des haarausfalls - Google Patents

Verwendung von lysin zur behandlung des haarausfalls

Info

Publication number
DE69716434D1
DE69716434D1 DE69716434T DE69716434T DE69716434D1 DE 69716434 D1 DE69716434 D1 DE 69716434D1 DE 69716434 T DE69716434 T DE 69716434T DE 69716434 T DE69716434 T DE 69716434T DE 69716434 D1 DE69716434 D1 DE 69716434D1
Authority
DE
Germany
Prior art keywords
pct
lysine
hair loss
treat hair
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69716434T
Other languages
English (en)
Other versions
DE69716434T2 (de
Inventor
Hugh Rushton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIO SCIENT Ltd
Original Assignee
BIO SCIENT Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO SCIENT Ltd filed Critical BIO SCIENT Ltd
Application granted granted Critical
Publication of DE69716434D1 publication Critical patent/DE69716434D1/de
Publication of DE69716434T2 publication Critical patent/DE69716434T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE69716434T 1996-06-10 1997-06-06 Verwendung von lysin zur behandlung des haarausfalls Expired - Fee Related DE69716434T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9612108A GB2314019B (en) 1996-06-10 1996-06-10 The use of L-Lysine in the treatment of hair loss
PCT/GB1997/001542 WO1997047276A1 (en) 1996-06-10 1997-06-06 The use of l-lysine in the treatment of hair loss

Publications (2)

Publication Number Publication Date
DE69716434D1 true DE69716434D1 (de) 2002-11-21
DE69716434T2 DE69716434T2 (de) 2003-06-18

Family

ID=10795046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716434T Expired - Fee Related DE69716434T2 (de) 1996-06-10 1997-06-06 Verwendung von lysin zur behandlung des haarausfalls

Country Status (14)

Country Link
US (1) US6136860A (de)
EP (1) EP0914078B1 (de)
JP (1) JP2000511876A (de)
AT (1) ATE226058T1 (de)
AU (1) AU721751B2 (de)
CA (1) CA2257607C (de)
DE (1) DE69716434T2 (de)
DK (1) DK0914078T3 (de)
ES (1) ES2185942T3 (de)
GB (1) GB2314019B (de)
HK (1) HK1019552A1 (de)
NZ (1) NZ333108A (de)
PT (1) PT914078E (de)
WO (1) WO1997047276A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1773600A (en) * 1998-12-21 2000-07-12 Aps Kbus 8 Nr. 4788 Topical treatment of skin disease
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
ITMI20011732A1 (it) * 2001-08-07 2003-02-07 Indena Spa Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto
ES2464169T3 (es) 2004-04-28 2014-05-30 Cosmo Oil Co., Ltd. Restaurador capilar
US7705010B2 (en) * 2005-02-22 2010-04-27 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
JP5315992B2 (ja) * 2006-06-08 2013-10-16 味の素株式会社 育毛用組成物
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
US10226462B2 (en) 2014-10-29 2019-03-12 Samson Clinical Pty Ltd Detection and treatment of excessive hair shedding
EP3175837A1 (de) 2015-12-01 2017-06-07 Noxell Corporation Verfahren zur haarbehandlung
EP3213747B1 (de) * 2016-03-04 2019-02-13 Laboratorio Reig Jofre S.A. Tabletten mit hohem gehalt an wirkstoffen zur behandlung von haarverlust oder zur anregung ihres wachstums
US20190269684A1 (en) * 2017-07-12 2019-09-05 Samson Clinical Pty Ltd Promoting hair growth and treatment of hair loss or excessive hair shedding

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB720561A (en) * 1952-04-17 1954-12-22 Frederick Victor Wells Improvements in preparations for application to the hair and scalp
LU54223A1 (de) * 1967-08-01 1969-03-24
BE789856A (fr) * 1971-10-13 1973-02-01 Tixier Georges Medicament a base de derives de la lysine susceptibles de stimuler differents metabolismes, en particulier la genese des leucocytes
DE3118882C2 (de) * 1981-05-13 1985-11-14 Rudolf V. Dr.rer.nat Dipl.-Chem. 5024 Pulheim Noronha Mittel gegen Haarausfall und zur Förderung des Haarwuchs
JPS60142908A (ja) * 1983-12-29 1985-07-29 Kanebo Ltd 養毛化粧料
WO1987000427A1 (en) * 1985-07-18 1987-01-29 Proctor Peter H Topical composition and method for stimulating hair growth
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
ATE110954T1 (de) * 1988-01-29 1994-09-15 Peter H Proctor Haarwachstumanregung mit nitroxyd und anderen radikalen.
FR2609393A1 (fr) * 1988-02-23 1988-07-15 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5133958A (en) * 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
US5122369A (en) * 1990-03-30 1992-06-16 Harmony Health Products, Inc. Nutrient composition for preventing hair loss
FR2669224B1 (fr) * 1990-11-15 1995-04-28 Marcel Contier Compositions capillaires, destinees notamment a la neutralisation de l'acide lactique du cuir chevelu et methode de traitement cosmetique du cuir chevelu.
GB9210768D0 (en) * 1992-05-20 1992-07-08 Unilever Plc Cosmetic composition
DE19520662A1 (de) * 1995-06-07 1996-12-12 Beiersdorf Ag Mittel zur Behandlung von Kopfschuppen und zur Behandlung der Haare

Also Published As

Publication number Publication date
ES2185942T3 (es) 2003-05-01
GB2314019A (en) 1997-12-17
CA2257607C (en) 2010-11-02
CA2257607A1 (en) 1997-12-18
DE69716434T2 (de) 2003-06-18
HK1019552A1 (en) 2000-02-18
GB2314019A8 (en) 1998-03-30
PT914078E (pt) 2003-02-28
ATE226058T1 (de) 2002-11-15
DK0914078T3 (da) 2003-02-17
JP2000511876A (ja) 2000-09-12
US6136860A (en) 2000-10-24
EP0914078B1 (de) 2002-10-16
WO1997047276A1 (en) 1997-12-18
AU721751B2 (en) 2000-07-13
GB2314019B (en) 2000-03-15
AU3040497A (en) 1998-01-07
NZ333108A (en) 2000-05-26
GB9612108D0 (en) 1996-08-14
EP0914078A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
DE69716434T2 (de) Verwendung von lysin zur behandlung des haarausfalls
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE69719408T2 (de) Verwendung von Strontiumsälze zur Behandlung von Arthrose
DE69827001D1 (de) Gewebedezellularization
DE59009034D1 (de) Desodorierende kosmetische mittel.
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
ATE49115T1 (de) Haarbehandlungsmittel.
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
DE69402826T2 (de) Zusammensetzung zur haarpflege
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
DE69427116T2 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
GR3027682T3 (en) 4-guanidinobutyramide for improving blood circulation.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee